Watch Channel 9’s interview with Isopogen founder and Chief Executive Officer, Dr Marian Sturm.
Life-changing cellular medicine
At Isopogen, we’re changing the lives of patients with auto-immune disease through our patented cellular technology, StemSmart
The quest to conquer Crohn's
With an 80% clinical response and 53% clinical remission, Isopogen’s StemSmart is the only Mesenchymal Stem Cell (MSC) technology to show clinical efficacy in Crohn’s sufferers